QuantHealth raises $45.0M Series B (Israel, Aug 2026)
Reach the investors backing rounds like this
Backed by Qumra Capital, Pitango HealthTech +6 more · verified emails and LinkedIn on Datapile
QuantHealth raises $45 million Series B to bring AI simulations to the costly world of clinical trials - calcalistech.com
QuantHealth develops AI-based simulations for clinical trials, helping drugmakers test decisions before enrolling patients or committing significant capital. The company aims to improve the efficiency and success rates of clinical trials, which are often costly and uncertain.
QuantHealth raises $45 million Series B to bring AI simulations to the costly world of clinical trials calcalistech.com
| Oct 01, 2026 | Inferize | $10.0M | Seed | Israel |
| Oct 01, 2026 | enso | $15.0M | Series A | Israel |
| Sep 23, 2026 | Irregular | $100.0M | — | Israel |
| Sep 23, 2026 | UltraSight | $24.0M | — | Israel |
9,000 investors back startups in Israel
You just read who funded QuantHealth. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.